130 related articles for article (PubMed ID: 34411785)
1. SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis.
Luci C; Vieira E; Bourinet M; Rousseau D; Bonnafous S; Patouraux S; Lefevre L; Larbret F; Prod'homme V; Iannelli A; Tran A; Anty R; Bailly-Maitre B; Deckert M; Gual P
Cell Mol Gastroenterol Hepatol; 2022; 13(1):173-191. PubMed ID: 34411785
[TBL] [Abstract][Full Text] [Related]
2. Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells.
Chihara K; Kato Y; Yoshiki H; Takeuchi K; Fujieda S; Sada K
Sci Rep; 2017 Sep; 7(1):11480. PubMed ID: 28904407
[TBL] [Abstract][Full Text] [Related]
3. Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
Torres-Hernandez A; Wang W; Nikiforov Y; Tejada K; Torres L; Kalabin A; Wu Y; Haq MIU; Khan MY; Zhao Z; Su W; Camargo J; Hundeyin M; Diskin B; Adam S; Rossi JAK; Kurz E; Aykut B; Shadaloey SAA; Leinwand J; Miller G
Oncogene; 2019 Jun; 38(23):4512-4526. PubMed ID: 30742098
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of 3BP2 is indispensable for the interaction with VAV3 in chicken DT40 cells.
Chihara K; Kimura Y; Honjoh C; Yamauchi S; Takeuchi K; Sada K
Exp Cell Res; 2014 Mar; 322(1):99-107. PubMed ID: 24406398
[TBL] [Abstract][Full Text] [Related]
6. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
[TBL] [Abstract][Full Text] [Related]
7. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.
Foucault I; Le Bras S; Charvet C; Moon C; Altman A; Deckert M
Blood; 2005 Feb; 105(3):1106-13. PubMed ID: 15345594
[TBL] [Abstract][Full Text] [Related]
8. Adaptor protein 3BP2 and cherubism.
Hatani T; Sada K
Curr Med Chem; 2008; 15(6):549-54. PubMed ID: 18336269
[TBL] [Abstract][Full Text] [Related]
9. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
Levaot N; Voytyuk O; Dimitriou I; Sircoulomb F; Chandrakumar A; Deckert M; Krzyzanowski PM; Scotter A; Gu S; Janmohamed S; Cong F; Simoncic PD; Ueki Y; La Rose J; Rottapel R
Cell; 2011 Dec; 147(6):1324-39. PubMed ID: 22153076
[TBL] [Abstract][Full Text] [Related]
10. Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induce cytokine expression and NF-κB activation.
Chihara K; Chihara Y; Takeuchi K; Sada K
Biochem J; 2022 Feb; 479(4):503-523. PubMed ID: 35129602
[TBL] [Abstract][Full Text] [Related]
11. [The adaptor protein 3BP2 in leukocyte signaling].
Deckert M
Med Sci (Paris); 2006 Dec; 22(12):1081-6. PubMed ID: 17156730
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis.
Kurniawan DW; Jajoriya AK; Dhawan G; Mishra D; Argemi J; Bataller R; Storm G; Mishra DP; Prakash J; Bansal R
J Control Release; 2018 Oct; 288():227-238. PubMed ID: 30219279
[TBL] [Abstract][Full Text] [Related]
13. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation.
Deckert M; Tartare-Deckert S; Hernandez J; Rottapel R; Altman A
Immunity; 1998 Nov; 9(5):595-605. PubMed ID: 9846481
[TBL] [Abstract][Full Text] [Related]
14. 3BP2 adapter protein is required for receptor activator of NFκB ligand (RANKL)-induced osteoclast differentiation of RAW264.7 cells.
GuezGuez A; Prod'homme V; Mouska X; Baudot A; Blin-Wakkach C; Rottapel R; Deckert M
J Biol Chem; 2010 Jul; 285(27):20952-63. PubMed ID: 20439986
[TBL] [Abstract][Full Text] [Related]
15. Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.
Kittaka M; Yoshimoto T; Schlosser C; Rottapel R; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2020 Feb; 35(2):382-395. PubMed ID: 31613396
[TBL] [Abstract][Full Text] [Related]
16. Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.
Matsumoto Y; Dimitriou ID; La Rose J; Lim M; Camilleri S; Law N; Adissu HA; Tong J; Moran MF; Chruscinski A; He F; Asano Y; Katsuyama T; Sada KE; Wada J; Rottapel R
J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35362478
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.
Shukla U; Hatani T; Nakashima K; Ogi K; Sada K
J Biol Chem; 2009 Dec; 284(49):33719-28. PubMed ID: 19833725
[TBL] [Abstract][Full Text] [Related]
18. Role of spleen tyrosine kinase in liver diseases.
Kurniawan DW; Storm G; Prakash J; Bansal R
World J Gastroenterol; 2020 Mar; 26(10):1005-1019. PubMed ID: 32205992
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.
Qu C; Zheng D; Li S; Liu Y; Lidofsky A; Holmes JA; Chen J; He L; Wei L; Liao Y; Yuan H; Jin Q; Lin Z; Hu Q; Jiang Y; Tu M; Chen X; Li W; Lin W; Fuchs BC; Chung RT; Hong J
Hepatology; 2018 Sep; 68(3):1125-1139. PubMed ID: 29537660
[TBL] [Abstract][Full Text] [Related]
20. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase.
Maeno K; Sada K; Kyo S; Miah SM; Kawauchi-Kamata K; Qu X; Shi Y; Yamamura H
J Biol Chem; 2003 Jul; 278(27):24912-20. PubMed ID: 12709437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
